DK0842185T3 - Ara-C-derivater - Google Patents

Ara-C-derivater

Info

Publication number: DK0842185T3
Authority: DK; Denmark
Prior art keywords: ara; derivatives; eicosenoyl; elaidoyl; cis
Prior art date: 1995-07-25

Application number

DK96926032T

Other languages

Danish (da)

English (en)

Inventor

Finn Myhren

Bernt Boerretzen

Are Dalen

Kjell Torgeir Stokke

Original Assignee

Norsk Hydro As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-25

Filing date

1996-07-12

Publication date

2002-02-04

1996-07-12 Application filed by Norsk Hydro As filed Critical Norsk Hydro As

2002-02-04 Application granted granted Critical

2002-02-04 Publication of DK0842185T3 publication Critical patent/DK0842185T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyamides (AREA)
Artificial Filaments (AREA)

DK96926032T 1995-07-25 1996-07-12 Ara-C-derivater DK0842185T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9515279.9A GB9515279D0 (en)	1995-07-25	1995-07-25	Improved therapeutic agents
PCT/NO1996/000179 WO1997005154A1 (en)	1995-07-25	1996-07-12	Improved therapeutic agents

Publications (1)

Publication Number	Publication Date
DK0842185T3 true DK0842185T3 (da)	2002-02-04

Family

ID=10778247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96926032T DK0842185T3 (da)	1995-07-25	1996-07-12	Ara-C-derivater

Country Status (25)

Country	Link
US (2)	US6316425B1 (no)
EP (1)	EP0842185B1 (no)
JP (2)	JP4372227B2 (no)
KR (1)	KR100401909B1 (no)
AT (1)	ATE207076T1 (no)
AU (1)	AU714814B2 (no)
CA (1)	CA2227533C (no)
CZ (1)	CZ291612B6 (no)
DE (1)	DE69616074T2 (no)
DK (1)	DK0842185T3 (no)
ES (1)	ES2166900T3 (no)
GB (1)	GB9515279D0 (no)
HU (1)	HU224839B1 (no)
IL (2)	IL122942A0 (no)
MX (1)	MX9800622A (no)
NO (1)	NO313985B1 (no)
NZ (1)	NZ313790A (no)
PL (1)	PL183601B1 (no)
PT (1)	PT842185E (no)
RU (1)	RU2165260C2 (no)
SK (1)	SK283003B6 (no)
TW (1)	TW434251B (no)
UA (1)	UA55389C2 (no)
WO (1)	WO1997005154A1 (no)
ZA (1)	ZA966047B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458772B1 (en)	1909-10-07	2002-10-01	Medivir Ab	Prodrugs
CA2271135A1 (en) *	1996-11-12	1998-05-22	Medivir Ab	Nucleosides
UA67736C2 (uk) *	1997-01-24	2004-07-15	Конфарма Ас	Похідні гемцитабіну, спосіб їх одержання та фармацевтична композиція на їх основі
US7393862B2 (en)	2002-05-17	2008-07-01	Celgene Corporation	Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
US20070160554A1 (en) *	2003-11-03	2007-07-12	Cognis Ip Management Gmbh	Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same
NO324263B1 (no) *	2005-12-08	2007-09-17	Clavis Pharma Asa	Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en) *	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
CA2700207A1 (en) *	2007-09-26	2009-04-02	Mount Sinai School Of Medicine	Azacytidine analogues and uses thereof
GB0808357D0 (en) *	2008-05-08	2008-06-18	Cyclacel Ltd	Process
EP2501364A4 (en) *	2009-11-20	2012-10-24	Clavis Pharma Asa	PARENTERAL FORMULATIONS FROM GEMCITABIN DERIVATIVES
RU2571283C2 (ru)	2010-07-13	2015-12-20	Клавис Фарма Аса	Парентеральные составы производных элацитарабина
KR20170082650A (ko) *	2012-03-28	2017-07-14	후지필름 가부시키가이샤	1-(2-디옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 염
EP3740287A4 (en)	2018-01-15	2021-11-03	Yinuoke Medicine Science And Technology Company Ltd.	TREATMENTS FOR CACHEXIA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3894000A (en) *	1971-01-27	1975-07-08	Upjohn Co	Ara-cytidine derivatives and process of preparation
FI105556B (fi)	1991-09-30	2000-09-15	Sankyo Co	Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
GB9307043D0 (en)	1993-04-05	1993-05-26	Norsk Hydro As	Chemical compounds
US5641758A (en)	1993-11-10	1997-06-24	Kluge; Michael	Cytarabine derivatives, the preparation and use thereof

1995
- 1995-07-25 GB GBGB9515279.9A patent/GB9515279D0/en active Pending
1996
- 1996-07-12 SK SK80-98A patent/SK283003B6/sk not_active IP Right Cessation
- 1996-07-12 DE DE69616074T patent/DE69616074T2/de not_active Expired - Lifetime
- 1996-07-12 CZ CZ1998163A patent/CZ291612B6/cs not_active IP Right Cessation
- 1996-07-12 PT PT96926032T patent/PT842185E/pt unknown
- 1996-07-12 KR KR10-1998-0700463A patent/KR100401909B1/ko not_active IP Right Cessation
- 1996-07-12 DK DK96926032T patent/DK0842185T3/da active
- 1996-07-12 PL PL96324690A patent/PL183601B1/pl not_active IP Right Cessation
- 1996-07-12 RU RU98103238/04A patent/RU2165260C2/ru not_active IP Right Cessation
- 1996-07-12 IL IL12294296A patent/IL122942A0/xx active IP Right Grant
- 1996-07-12 ES ES96926032T patent/ES2166900T3/es not_active Expired - Lifetime
- 1996-07-12 JP JP50750497A patent/JP4372227B2/ja not_active Expired - Fee Related
- 1996-07-12 AU AU66335/96A patent/AU714814B2/en not_active Ceased
- 1996-07-12 AT AT96926032T patent/ATE207076T1/de active
- 1996-07-12 HU HU9900924A patent/HU224839B1/hu not_active IP Right Cessation
- 1996-07-12 US US08/983,483 patent/US6316425B1/en not_active Expired - Lifetime
- 1996-07-12 WO PCT/NO1996/000179 patent/WO1997005154A1/en active IP Right Grant
- 1996-07-12 EP EP96926032A patent/EP0842185B1/en not_active Expired - Lifetime
- 1996-07-12 NZ NZ313790A patent/NZ313790A/xx not_active IP Right Cessation
- 1996-07-12 CA CA002227533A patent/CA2227533C/en not_active Expired - Fee Related
- 1996-07-16 ZA ZA9606047A patent/ZA966047B/xx unknown
- 1996-10-02 TW TW085111996A patent/TW434251B/zh not_active IP Right Cessation
- 1996-12-07 UA UA98020922A patent/UA55389C2/uk unknown
1998
- 1998-01-15 IL IL122942A patent/IL122942A/en not_active IP Right Cessation
- 1998-01-21 MX MX9800622A patent/MX9800622A/es not_active IP Right Cessation
- 1998-01-23 NO NO19980296A patent/NO313985B1/no not_active IP Right Cessation
1999
- 1999-11-09 US US09/435,641 patent/US6335322B1/en not_active Expired - Fee Related
2009
- 2009-07-03 JP JP2009159081A patent/JP5087052B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO980296L (no)	1998-01-23
JP2002504068A (ja)	2002-02-05
CA2227533C (en)	2007-01-09
UA55389C2 (uk)	2003-04-15
HUP9900924A2 (hu)	2001-05-28
KR19990035804A (ko)	1999-05-25
CZ16398A3 (cs)	1998-06-17
JP2009215326A (ja)	2009-09-24
NO313985B1 (no)	2003-01-13
US6335322B1 (en)	2002-01-01
RU2165260C2 (ru)	2001-04-20
EP0842185B1 (en)	2001-10-17
US6316425B1 (en)	2001-11-13
NO980296D0 (no)	1998-01-23
JP4372227B2 (ja)	2009-11-25
TW434251B (en)	2001-05-16
JP5087052B2 (ja)	2012-11-28
AU714814B2 (en)	2000-01-13
KR100401909B1 (ko)	2004-02-14
IL122942A0 (en)	1999-05-09
SK8098A3 (en)	1998-07-08
PT842185E (pt)	2002-04-29
GB9515279D0 (en)	1995-09-20
CZ291612B6 (cs)	2003-04-16
PL324690A1 (en)	1998-06-08
ZA966047B (en)	1997-02-04
IL122942A (en)	2006-12-10
HU224839B1 (en)	2006-03-28
ES2166900T3 (es)	2002-05-01
PL183601B1 (pl)	2002-06-28
WO1997005154A1 (en)	1997-02-13
CA2227533A1 (en)	1997-02-13
DE69616074D1 (de)	2001-11-22
EP0842185A1 (en)	1998-05-20
DE69616074T2 (de)	2002-06-06
NZ313790A (en)	1999-07-29
MX9800622A (es)	1998-11-30
AU6633596A (en)	1997-02-26
HUP9900924A3 (en)	2001-06-28
ATE207076T1 (de)	2001-11-15
SK283003B6 (sk)	2003-01-09

Publication	Publication Date	Title
EE9800227A (et)	1998-12-15	17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
DK0747050T4 (da)	2013-05-21	Farmaceutiske sammensætninger, der indeholder irbesartan
ATE255819T1 (de)	2003-12-15	Zusammensetzungen von süssigkeiten
MA25279A1 (fr)	2001-12-31	Compositions rafraichissantes.
DE19681287T1 (de)	1998-03-19	Orale Formulierung von 2-Methylthienobenzodiazepin
BR9508247A (pt)	1997-12-23	Derivados de 2-arilciclopentano-2,3-dionas
BR9612201A (pt)	1999-07-13	Derivados da tirosina
DE59709414D1 (de)	2003-04-03	Oxyiminopregnancarbolactone
BR9611130A (pt)	1999-03-30	Derivados de 3-aril-5-halógeno-pirona
PT1000048E (pt)	2003-03-31	Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
BR9711586A (pt)	1999-08-24	Compostos e uso dos mesmo
EP0932606A4 (en)	2000-01-19	Inhibitors of prenyl transferases
DK0842185T3 (da)	2002-02-04	Ara-C-derivater
PT921125E (pt)	2002-06-28	Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
BR9610530A (pt)	1999-07-06	Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos
NO981195D0 (no)	1998-03-17	Nye aminoresin sammensetninger
BR9607046A (pt)	1997-12-30	Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
BR9609723A (pt)	1999-03-16	Derivados da tricetona
ES2162986T3 (es)	2002-01-16	Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69614552D1 (de)	2001-09-20	MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DE69611546D1 (de)	2001-02-15	Herstellung von 2,6-dimethylnaphthalin
DE69612049D1 (de)	2001-04-19	Campherderivate als Duftmittel
PT796843E (pt)	2003-09-30	Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
NO965165L (no)	1997-06-05	Anvendelse av 8,9-dehydroestron som en antioksydant
NO974458D0 (no)	1997-09-26	Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater